| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medicine (M.P., M.J.E.), Department of Orthopaedic Surgery (C.H.T.), and Department of Medical and Molecular Genetics (M.J.E., T.F.), Indiana University School of Medicine, Indianapolis, Indiana 46202; and Department of Biomedical Engineering (C.H.T.), Indiana University Purdue University, Indianapolis, Indiana 46202
Correspondence: Address all correspondence and requests for reprints to: Munro Peacock, M.D., General Clinical Research Center, University Hospital and Outpatient Center, Room 5595, 550 North University Boulevard, Indianapolis, Indiana 46202. E-mail: mpeacock{at}iupui.edu
Osteoporosis is a common multifactorial disorder of reduced bone mass. The disorder in its most common form is generalized, affecting the elderly, both sexes, and all racial groups. Multiple environmental factors are involved in the pathogenesis. Genes also play a major role as reflected by heritability of many components of bone strength. Quantitative phenotypes in bone strength in the normal population do not conform to a monogenetic mode of inheritance. The common form of osteoporosis is generally considered to be a polygenic disorder arising from the interaction of common polymorphic alleles at quantitative trait loci, with multiple environmental factors. Finding the susceptibility genes underlying osteoporosis requires identifying specific alleles that coinherit with key heritable phenotypes in bone strength. Because of the close correspondence among mammalian genomes, identification of the genes underlying bone strength in mammals such as the mouse is likely to be of major assistance in human studies. Identification of susceptibility genes for osteoporosis is one of several important approaches toward the long-term goal of understanding the molecular biology of the normal variation in bone strength and how it may be modified to prevent osteoporosis. As with all genetic studies in humans, these scientific advances will need to be made in an environment of legal and ethical safeguards that are acceptable to the general public.
This article has been cited by other articles:
 |
|
 |
|
  J. F Aloia African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox Am. J. Clinical Nutrition, August 1, 2008; 88(2): 545S - 550S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Styrkarsdottir, B. V. Halldorsson, S. Gretarsdottir, D. F. Gudbjartsson, G. B. Walters, T. Ingvarsson, T. Jonsdottir, J. Saemundsdottir, J. R. Center, T. V. Nguyen, et al. Multiple Genetic Loci for Bone Mineral Density and Fractures N. Engl. J. Med., May 29, 2008; 358(22): 2355 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Galusca, M. Zouch, N. Germain, C. Bossu, D. Frere, F. Lang, M.-H. Lafage-Proust, T. Thomas, L. Vico, and B. Estour Constitutional Thinness: Unusual Human Phenotype of Low Bone Quality J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 110 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Braun, C. Palacios, K. Wigertz, L. A Jackman, R. J Bryant, L. D McCabe, B. R Martin, G. P McCabe, M. Peacock, and C. M Weaver Racial differences in skeletal calcium retention in adolescent girls with varied controlled calcium intakes Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1657 - 1663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Chandler, K. J. Chandler, K. A. McFarland, and D. P. Mortlock Bmp2 Transcription in Osteoblast Progenitors Is Regulated by a Distant 3' Enhancer Located 156.3 Kilobases from the Promoter Mol. Cell. Biol., April 15, 2007; 27(8): 2934 - 2951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Riancho, C. Valero, A. Naranjo, D. J. Morales, C. Sanudo, and M. T. Zarrabeitia Identification of an Aromatase Haplotype That Is Associated with Gene Expression and Postmenopausal Osteoporosis J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 660 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Oh, S.-Y. Kim, D. J. Kim, J. Y. Lee, J.-K. Lee, K. Kimm, B. L. Park, H. D. Shin, T.-H. Kim, E. K. Park, et al. Associations of catalase gene polymorphisms with bone mineral density and bone turnover markers in postmenopausal women J. Med. Genet., January 1, 2007; 44(1): e62 - e62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Lee and M. A. Tucker Making Sense of Puzzling Genetic Association Studies: A Team Approach Ann Intern Med, August 15, 2006; 145(4): 302 - 304. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Riancho, M. T Zarrabeitia, C. Valero, C. Sanudo, V. Mijares, and J. Gonzalez-Macias A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density. Eur. J. Endocrinol., July 1, 2006; 155(1): 53 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Schipani, A. Zallone, G. J. Strewler, J. W. Pike, S. Ferrari, Y. Jiang, and E. Seeman Meeting Report from the 27th Annual Meeting of the American Society for Bone and Mineral Research: September 23-27, 2005 in Nashville, Tennessee, USA IBMS BoneKEy, January 1, 2006; 3(1): 29 - 62. [Full Text] [PDF]
|
|
|
|
|
|
Y.-T. Sheu, J. M. Zmuda, J. A. Cauley, S. P. Moffett, C. J. Rosen, C. Ishwad, and R. E. Ferrell Nuclear Receptor Coactivator-3 Alleles Are Associated with Serum Bioavailable Testosterone, Insulin-Like Growth Factor-1, and Vertebral Bone Mass in Men J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 307 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ichikawa, D. L. Koller, M. Peacock, M. L. Johnson, D. Lai, S. L. Hui, C. C. Johnston, T. M. Foroud, and M. J. Econs Polymorphisms in the Estrogen Receptor {beta} (ESR2) Gene Are Associated with Bone Mineral Density in Caucasian Men and Women J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5921 - 5927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Michaelsson, H. Melhus, H. Ferm, A. Ahlbom, and N. L. Pedersen Genetic Liability to Fractures in the Elderly Arch Intern Med, September 12, 2005; 165(16): 1825 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Havill, M. C. Mahaney, L. A. Cox, P. A. Morin, G. Joslyn, and J. Rogers A Quantitative Trait Locus for Normal Variation in Forearm Bone Mineral Density in Pedigreed Baboons Maps to the Ortholog of Human Chromosome 11q J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3638 - 3645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Acheson Bone Density and the Risk of Fractures: Should Treatment Thresholds Vary by Race? JAMA, May 4, 2005; 293(17): 2151 - 2154. [Full Text] [PDF]
|
|
|
|
|
|
M. Peacock, D. L. Koller, T. Fishburn, S. Krishnan, D. Lai, S. Hui, C. C. Johnston, T. Foroud, and M. J. Econs Sex-Specific and Non-Sex-Specific Quantitative Trait Loci Contribute to Normal Variation in Bone Mineral Density in Men J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3060 - 3066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Donath, G. Speer, G. Poor, P. Gergely Jr, A. Tabak, and P. Lakatos Vitamin D receptor, oestrogen receptor-{alpha} and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone Rheumatology, June 1, 2004; 43(6): 692 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. V. N. Bodine, W. Zhao, Y. P. Kharode, F. J. Bex, A.-J. Lambert, M. B. Goad, T. Gaur, G. S. Stein, J. B. Lian, and B. S. Komm The Wnt Antagonist Secreted Frizzled-Related Protein-1 Is a Negative Regulator of Trabecular Bone Formation in Adult Mice Mol. Endocrinol., May 1, 2004; 18(5): 1222 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Klein, J. Allard, Z. Avnur, T. Nikolcheva, D. Rotstein, A. S. Carlos, M. Shea, R. V. Waters, J. K. Belknap, G. Peltz, et al. Regulation of Bone Mass in Mice by the Lipoxygenase Gene Alox15 Science, January 9, 2004; 303(5655): 229 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Somner, S. McLellan, J. Cheung, Y. T. Mak, M. L. Frost, K. M. Knapp, A. S. Wierzbicki, M. Wheeler, I. Fogelman, S. H. Ralston, et al. Polymorphisms in the P450 c17 (17-Hydroxylase/17,20-Lyase) and P450 c19 (Aromatase) Genes: Association with Serum Sex Steroid Concentrations and Bone Mineral Density in Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 344 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kasukawa, D. J. Baylink, J. E. Wergedal, Y. Amaar, A. K. Srivastava, R. Guo, and S. Mohan Lack of Insulin-Like Growth Factor I Exaggerates the Effect of Calcium Deficiency on Bone Accretion in Mice Endocrinology, November 1, 2003; 144(11): 4682 - 4689. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
